KalVista Pharmaceuticals (KALV)
(Delayed Data from NSDQ)
$11.69 USD
+0.08 (0.69%)
Updated May 22, 2024 04:00 PM ET
After-Market: $11.73 +0.04 (0.34%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
07/05/2024
Time: -- |
4/2024 | $-0.71 | -19.15% |
Earnings Summary
For their last quarter, KalVista Pharmaceuticals (KALV) reported earnings of -$0.84 per share, missing the Zacks Consensus Estimate of -$0.75 per share. This reflects a negative earnings surprise of 12.00%. Look out for KALV's next earnings release expected on July 05, 2024. For the next earning release, we expect the company to report earnings of -$0.71 per share, reflecting a year-over-year increase of 7.79%.
Earnings History
Price & Consensus
Zacks News for KALV
Are Medical Stocks Lagging Cabaletta Bio (CABA) This Year?
KALV: What are Zacks experts saying now?
Zacks Private Portfolio Services